Analysis and Perspectives

Feb 12, 2025

Donanemab is a promising new Alzheimer’s disease treatment. Donanemab has the potential to rule the Alzheimer’s disease market.

Feb 12, 2025

Despite facing significant setbacks, companies such as Eli Lilly, BioVie, and others are developing effective Alzheimer's disease treatments.

Feb 06, 2025

Polycythemia vera treatment market is expected to substantially change and it will be dominated by approved products, JAKAFI and BESREMi.

Jan 06, 2025

Parkinson's disease treatment market to expand owing to novel therapies being developed by companies such as AZ, Cortexyme, and others.

Nov 29, 2024

The evolving landscape of NSCLC treatment presents significant market opportunities for pharmaceutical companies to secure their place.

Nov 20, 2024

Despite decades of research, treatment options are limited in the ARDS market. There are only a few treatments available in the ARDS market. The mainstay of management remains supportive care with mechanical ventilation. Other ARDS treatment options for patients include supplemental oxygen, prone positioning, the u...

Nov 20, 2024

As no approved drug in the ARDS market, uptake of emerging therapies is expected to be high. Currently, several assets are in the ARDS pipeline.

Nov 20, 2024

Acute respiratory distress syndrome (ARDS) prevalence is increasing drastically owing to certain factors such as pneumonia, COVID-19, sepsis,

Nov 08, 2024

It is estimated that the cervical cancer treatment space will experience significant changes during the forecast period of 2024–2034. The future is brighter for patients with cervical cancer. Targeted agents and biomarker-driven therapies hold promise for improved outcomes both as single agents and combinations.

Nov 08, 2024

The HPV vaccine protects against several types of HPV that can cause different types of cancers, which mainly include cervical cancer